EUVIMEDEUVIMED entdecken
Crossref

Emerging mRNA-based nanomedicines for cancer immunotherapy

Chenxi Yu, Xuetong Wu, Shamei Luo, Hanyong Wang, Chenlu Huang, Linhua Zhang, Dunwan Zhu

Chinese Chemical Letters · 2026-08 · 113288

DOI: 10.1016/j.cclet.2026.113288 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chinese Chemical Letters, 2026-08. Verfasst von Chenxi Yu und 6 weiteren Autor:innen. Die Arbeit nennt 204 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Science and Technology Major Project, Natural Science Foundation of Tianjin Municipality.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Key Research and Development Program of China
  • National Science and Technology Major Project
  • Natural Science Foundation of Tianjin Municipality

Zitieren

APA

Yu, C., Wu, X., Luo, S., Wang, H., Huang, C., Zhang, L., & Zhu, D. (2026). Emerging mRNA-based nanomedicines for cancer immunotherapy. Chinese Chemical Letters, 113288. https://doi.org/10.1016/j.cclet.2026.113288

Vancouver

Yu C, Wu X, Luo S, Wang H, Huang C, Zhang L, et al. Emerging mRNA-based nanomedicines for cancer immunotherapy. Chinese Chemical Letters. 2026:113288. doi:10.1016/j.cclet.2026.113288

BibTeX
@article{Yu2026,
  author = {Yu, Chenxi and Wu, Xuetong and Luo, Shamei and Wang, Hanyong and Huang, Chenlu and Zhang, Linhua and Zhu, Dunwan},
  title = {Emerging mRNA-based nanomedicines for cancer immunotherapy},
  journal = {Chinese Chemical Letters},
  year = {2026},
  pages = {113288},
  doi = {10.1016/j.cclet.2026.113288}
}
Kostenlos starten →